Tirzepatide is a dual GIP/GLP-1 receptor agonist that simultaneously occupies GLP-1 and GIP receptors
Theyre also less interested in alcohol, which can result in severe hangovers even if GLP-1 users drink them in small quantities, as well as caffeinated drinks, which can upset their stomachs, and carbonated beverages, which make them feel too full
Conceptual and methodological pitfalls in experimental studies: an overview, and the case of Alzheimers disease
GLP-1 drugs have been used by large shares of adults who say they have been diagnosed with diabetes (57% have ever used the drug, including 45% who are currently using), heart disease (40% ever, 29% currently), or as obese or overweight in the past five years (34% ever, 23% currently)
is a member of SFB1425, funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Community pathways for the early detection and risk stratification of chronic liver disease: A narrative systematic review